Literature DB >> 27064753

Effect of Transplant Center Volume on Cost and Readmissions in Medicare Lung Transplant Recipients.

Joshua J Mooney1, David Weill1, Jack H Boyd2, Mark R Nicolls1, Jay Bhattacharya3, Gundeep S Dhillon1.   

Abstract

RATIONALE: Although lung transplant recipient survival is better at higher volume centers, the effect of center volume on admission cost and early hospital readmission is unknown.
OBJECTIVES: To understand the association between transplant center volume and recipient risk-adjusted transplant admission cost, in-hospital mortality, and early hospital readmission in lung transplant recipients.
METHODS: Medicare lung transplant recipients from May 4, 2005 to December 31, 2011 were identified through linkage of transplant registry and Medicare administrative claims. Transplant admission cost was extracted, adjusted for regional price variation, and compared across low-, intermediate-, and high-volume centers. A multivariable hierarchical generalized linear regression model was used to assess the effect of transplant center volume on recipient adjusted cost. Modified Poisson regression models were used to assess adjusted in-hospital mortality and early hospital readmission by transplant center volume.
MEASUREMENTS AND MAIN RESULTS: There were 3,128 Medicare lung transplant recipients identified. Unadjusted transplant cost was lower at high-volume centers (mean, $131,352 [SD, ±$106,165]; median, $90,177; interquartile range [IQR], $79,165-$137,915) than at intermediate-volume (mean, $138,792 [SD, ±$106,270]; median, $93,024; IQR, $82,700-$154,857) or low-volume (mean, $143,609 [SD, ±$123,316]; median, $95,234; IQR, $83,052-$152,149) centers (P < 0.0001). After adjusting for recipient health risk, low-volume centers had an 11.66% greater transplant admission cost (P = 0.040), a 41% greater risk for in-hospital mortality (P = 0.015), and a 14% greater risk for early hospital readmission (P = 0.033) compared with high-volume centers. There was no significant difference in transplant cost, in-hospital mortality, or early hospital readmission between intermediate- and high-volume centers.
CONCLUSIONS: Lung transplant admission cost, in-hospital mortality, and early hospital readmission rate are lower at high-volume centers compared with low-volume centers.

Keywords:  costs and cost analysis; economics; lung transplantation

Mesh:

Year:  2016        PMID: 27064753      PMCID: PMC5015751          DOI: 10.1513/AnnalsATS.201601-017OC

Source DB:  PubMed          Journal:  Ann Am Thorac Soc        ISSN: 2325-6621


  25 in total

1.  A modified poisson regression approach to prospective studies with binary data.

Authors:  Guangyong Zou
Journal:  Am J Epidemiol       Date:  2004-04-01       Impact factor: 4.897

2.  OPTN/SRTR 2013 Annual Data Report: economics.

Authors:  M A Schnitzler; M A Skeans; D A Axelrod; K L Lentine; J E Tuttle-Newhall; J J Snyder; A K Israni; B L Kasiske
Journal:  Am J Transplant       Date:  2015-01       Impact factor: 8.086

3.  Geographic disparities in access to lung transplantation before and after implementation of the lung allocation score.

Authors:  G Thabut; J Munson; K Haynes; M O Harhay; J D Christie; S D Halpern
Journal:  Am J Transplant       Date:  2012-08-06       Impact factor: 8.086

4.  Transplantation: early hospital readmissions after kidney transplantation.

Authors:  Martha Pavlakis
Journal:  Nat Rev Nephrol       Date:  2014-03-04       Impact factor: 28.314

5.  Prices don't drive regional Medicare spending variations.

Authors:  Daniel J Gottlieb; Weiping Zhou; Yunjie Song; Kathryn Gilman Andrews; Jonathan S Skinner; Jason M Sutherland
Journal:  Health Aff (Millwood)       Date:  2010-01-28       Impact factor: 6.301

6.  Early hospital readmission after kidney transplantation: patient and center-level associations.

Authors:  M A McAdams-Demarco; M E Grams; E C Hall; J Coresh; D L Segev
Journal:  Am J Transplant       Date:  2012-09-27       Impact factor: 8.086

7.  Single- vs double-lung transplantation in patients with chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis since the implementation of lung allocation based on medical need.

Authors:  Justin M Schaffer; Steve K Singh; Bruce A Reitz; Roham T Zamanian; Hari R Mallidi
Journal:  JAMA       Date:  2015-03-03       Impact factor: 56.272

8.  The influence of clinical variables on hospital costs after orthotopic liver transplantation.

Authors:  J F Whiting; J Martin; E Zavala; D Hanto
Journal:  Surgery       Date:  1999-02       Impact factor: 3.982

9.  Outlier payments for cardiac surgery and hospital quality.

Authors:  Onur Baser; Zhahoui Fan; Justin B Dimick; Douglas O Staiger; John D Birkmeyer
Journal:  Health Aff (Millwood)       Date:  2009 Jul-Aug       Impact factor: 6.301

10.  Understanding Inpatient Cost Variation in Kidney Transplantation: Implications for Payment Reforms.

Authors:  Chandy Ellimoottil; Zaojun Ye; Apurba K Chakrabarti; Michael J Englesbe; David C Miller; John T Wei; Amit K Mathur
Journal:  Urology       Date:  2015-09-14       Impact factor: 2.649

View more
  5 in total

1.  Causes, Preventability, and Cost of Unplanned Rehospitalizations Within 30 Days of Discharge After Lung Transplantation.

Authors:  Andrew M Courtwright; Derek Zaleski; Lisa Gardo; Vivek N Ahya; Jason D Christie; Maria Crespo; Denis Hadjiliadis; James Lee; Maria Molina; Namrata Patel; Mary Porteous; Edward E Cantu; Christian Bermudez; Joshua M Diamond
Journal:  Transplantation       Date:  2018-05       Impact factor: 4.939

2.  The Impact of Center Volume on Outcomes in Lung Transplantation.

Authors:  Zhizhou Yang; Melanie P Subramanian; Yan Yan; Bryan F Meyers; Benjamin D Kozower; G Alexander Patterson; Ruben G Nava; Ramsey R Hachem; Chad A Witt; Michael K Pasque; Derek E Byers; Hrishikesh S Kulkarni; Daniel Kreisel; Akinobu Itoh; Varun Puri
Journal:  Ann Thorac Surg       Date:  2021-04-20       Impact factor: 4.330

3.  Regionalization for thoracic surgery: Economic implications of regionalization in the United States.

Authors:  Melanie P Subramanian; Zhizhou Yang; Su-Hsin Chang; Varun Puri
Journal:  J Thorac Cardiovasc Surg       Date:  2020-11-19       Impact factor: 5.209

4.  Geographic Differences in Lung Transplant Volume and Donor Availability During the COVID-19 Pandemic.

Authors:  Luke Benvenuto; Mark E Snyder; Meghan Aversa; Shreena Patel; Joseph Costa; Lori Shah; Hilary Robbins; Frank D'Ovidio; Joshua Sonett; Bryan P Stanifer; Philippe Lemaitre; Selim Arcasoy; Michaela R Anderson
Journal:  Transplantation       Date:  2021-04-01       Impact factor: 5.385

5.  What Awaits on the Other Side: Post-Lung Transplant Morbidity and Mortality After Pre-Transplant Hospitalization.

Authors:  Darya Rudym; Luke Benvenuto; Joseph Costa; Meghan Aversa; Hilary Robbins; Lori Shah; Hanyoung Kim; Bryan P Stanifer; Joshua Sonett; Frank D'Ovidio; Selim M Arcasoy
Journal:  Ann Transplant       Date:  2020-08-18       Impact factor: 1.530

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.